Table of Contents Table of Contents
Previous Page  259 / 330 Next Page
Information
Show Menu
Previous Page 259 / 330 Next Page
Page Background

CAP GEMINI AND ITS SHAREHOLDERS

5.1 Cap Gemini share capital

5

259

Registration Document 2016 — Capgemini

authorizations

5.1.2

share capital

Authorizations granted by the Combined Shareholders’ Meeting to the Board of Directors to increase

The following table summarizes (pursuant, to Article L.225-100 of the French Commercial Code) authorizations still in effect and those that

have expired since the last Combined Shareholders’ Meeting.

Purpose of the authorization

amount

(1) (2)

(in euros)

Maximum

number

date and

resolution

Authorization

Expiry date

Used during 2016

program

Purchase by the Company of its own

a)

shares under a share buyback

10% of share

capital

05/18/2016/

10

th

11/18/2017 4,128,337 shares were purchased under the

share buyback program (excluding the

Liquidity contract) at an average price of

€81.18

As part of the Liquidity contract:

a) 2,686,396 shares purchased at an

average market price of €81.12

b) 2,621,396 shares sold at an average

market price of €81.33

c) The balance on 12/31/2016 is

150,000 shares and about €9 million.

Cancellation of treasury shares

10% of share

capital

period

per 12-month

05/18/2016/

11

th

07/18/2018

of the Board of Directors on 07/26/2016.

€50,129,800.47 were cancelled by decision

617,235 shares with a value of

additional paid-in capital, reserves,

profit or other eligible amounts

Share capital increase by capitalizing

c)

(par value)

€1.5 billion 05/18/2016/

12

th

07/18/2018

This authorization was not used in 2016

instruments,

with retention of PSR

Share capital increase by issuing

d)

granting a right to allocation of debt

shares and/or securities granting

access to the share capital, or

(par value)

€550 million

(issue amount)

€7.5 billion

05/18/2016/

13

th

07/18/2018

This authorization was not used in 2016

Share capital increase by issuing

e)

shares and/or securities granting

instruments,

with cancellation of

PSR, by public offering

access to the share capital, or

granting a right to allocation of debt

€137 million

(par value)

(issue amount)

€2.5 billion

05/18/2016/

14

th

07/18/2018

This authorization was not used in 2016

PSR, by private placement

granting a right to allocation of debt

instruments,

with cancellation of

shares and/or securities granting

access to the share capital, or

Share capital increase by issuing

f)

€137 million

(par value)

€2.5 billion

(issue amount)

05/18/2016/

15

th

07/18/2018

This authorization was not used in 2016

the context of a share capital

increase

with cancellation of PSR

Setting the issue price of shares in

€137 million

(par value)

€2.5 billion

(issue amount)

10% of share

capital

05/18/2016/

16

th

07/18/2018

This authorization was not used in 2016

“Greenshoe” option (d) to (g)

05/18/2016/17

th

07/18/2018

This authorization was not used in 2016

(1) Recap of overall limits:

a maximum par value amount of €550 million and a maximum issue amount of €7.5 billion for all issues with and without pre-emptive subscription rights;

including a maximum par value amount of €137 million and a maximum issue amount of €2.5 billion for all issues without pre-emptive subscription rights;

issues performed pursuant to j), k) and l) above are not included in these general limits.

Total share capital increases decided pursuant to j) and k) are capped at a maximum par value amount of €48 million.

(2)

Abbreviations: PSR = Pre-emptive Subscription Rights